These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2939216

  • 1. Double-blind comparison of ketanserin with atenolol: antihypertensive activity and effect on platelet function.
    Kirch W, Ohnhaus EE.
    J Hypertens Suppl; 1986 Apr; 4(1):S67-71. PubMed ID: 2939216
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A, Fagard R, Fiocchi R, Lijnen P, Staessen J, Vermylen J.
    J Cardiovasc Pharmacol; 1984 Apr; 6(1):182-5. PubMed ID: 6199602
    [Abstract] [Full Text] [Related]

  • 3. Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a post-synaptic alpha-blocker.
    Rosenthal J, Koehle W, Gruebel B, Fisher R.
    J Hypertens Suppl; 1986 Apr; 4(1):S85-7. PubMed ID: 2871145
    [Abstract] [Full Text] [Related]

  • 4. A double-blind comparative study of ketanserin with atenolol in essential hypertension.
    Antonicelli R, Andreoni A, Saccomanno G, Gambini C, Paciaroni E.
    Drugs Exp Clin Res; 1989 Apr; 15(11-12):577-81. PubMed ID: 2700320
    [Abstract] [Full Text] [Related]

  • 5. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A, Ceccanti M, Assogna G, Romeo M, Cavaleri G, Attilia ML.
    Int J Clin Pharmacol Res; 1988 Apr; 8(5):321-5. PubMed ID: 3068159
    [Abstract] [Full Text] [Related]

  • 6. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.
    Arneklo-Nobin B, Elmér O, Akesson A.
    Int Angiol; 1988 Apr; 7(1):19-25. PubMed ID: 3290356
    [Abstract] [Full Text] [Related]

  • 7. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
    Amstein R, Fetkovska N, Pletscher A, Bühler FR.
    J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of ketanserin and metoprolol in essential hypertension.
    Kane JA, Tooley M, Sibbald B, Gould SE.
    J Hypertens Suppl; 1986 Apr; 4(1):S63-5. PubMed ID: 2939215
    [Abstract] [Full Text] [Related]

  • 9. Clinical experience with ketanserin in the treatment of hypertension.
    Palermo A, Mara G, Pizza N, Costantini C, del Rosso G, Assogna G, Libretti A.
    J Hypertens Suppl; 1986 Apr; 4(1):S81-3. PubMed ID: 2939219
    [Abstract] [Full Text] [Related]

  • 10. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
    Novo S, Alaimo G, Abrignani MG, Giordano U, Avellone G, Pinto A, Adamo L, Cutietta A, Indovina A, Strano A.
    Int J Clin Pharmacol Res; 1986 Apr; 6(3):199-211. PubMed ID: 2943685
    [Abstract] [Full Text] [Related]

  • 11. Experience with ketanserin and ritanserin in hypertensive patients.
    Hedner T, Persson B.
    J Cardiovasc Pharmacol; 1988 Apr; 11 Suppl 1():S44-8. PubMed ID: 2459514
    [Abstract] [Full Text] [Related]

  • 12. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O, Rydén L.
    Acta Med Scand; 1981 Apr; 209(4):261-6. PubMed ID: 7015797
    [Abstract] [Full Text] [Related]

  • 13. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

  • 14. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
    Mauersberger H.
    J Hypertens Suppl; 1986 Apr; 4(1):S73-5. PubMed ID: 2939217
    [Abstract] [Full Text] [Related]

  • 15. Comparison of ketanserin and pindolol in hypertension.
    Gordin A, Saraste K, Turanlahti M, Sundberg S.
    J Hypertens Suppl; 1986 Apr; 4(1):S61-2. PubMed ID: 2939214
    [Abstract] [Full Text] [Related]

  • 16. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
    Andrén L, Svensson A, Dahlöf B, Eggertsen R, Hansson L.
    Acta Med Scand; 1983 Apr; 214(2):125-30. PubMed ID: 6353879
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

  • 18. [Comparative antihypertensive action of 20 mg delayed-action nifedipine with either 25 or 50 mg atenolol. A study on the treatment of patients with mild to moderately severe arterial hypertension].
    Kraft K, Schiessl S, Vetter H.
    Praxis (Bern 1994); 1996 Sep 03; 85(36):1081-6. PubMed ID: 8927880
    [Abstract] [Full Text] [Related]

  • 19. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov 03; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 20. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects.
    Ohman KP, Karlberg BE.
    Scand J Urol Nephrol Suppl; 1984 Nov 03; 79():93-7. PubMed ID: 6089325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.